Immunomedics Provides Update On Phase 2 Study Of Isactuzumab Govitecan; Hemispherx Reports New Evidence of Ampligen(R)

Print E-mail
By William Kent   
Thursday, 30 October 2014 19:00

Below is a look at some of the headlines for companies that made news in the healthcare sector on October 30, 2014.

Read more...
 

Cara Therapeutics Announces Positive Results Of Peripheral Opioid; POZEN Appoints Senior VP and Chief Business Officer

Print E-mail
By William Kent   
Wednesday, 29 October 2014 19:32
Below is a look at some of the headlines for companies that made news in the healthcare sector on October 29, 2014.
Read more...
 

Chembio Falling After Failing To Provide Timeline On Product Deployment; Ambit Announces Expiration of Hart-Scott-Rodino Waiting Period

Print E-mail
By Josh Gee   
Tuesday, 28 October 2014 21:28
Below is a look at some of the headlines for companies that made news in the healthcare sector on October 28, 2014.
Read more...
 

Novavax To Launch Clinical Trial Of Ebola Vaccine; Sarepta Announces Update on Eteplirsen

Print E-mail
By Marilyn Mullen   
Monday, 27 October 2014 15:55

Below is a look at some of the headlines for companies that made news in the healthcare sector on October 27, 2014.

Read more...
 

PlasmaTech Announces Reverse Stock Split, Launches New Corporate Website; CEL-SCI Announces Closing of Public Offering

Print E-mail
By Marilyn Mullen   
Friday, 24 October 2014 19:41
Below is a look at some of the headlines for companies that made news in the healthcare sector on October 24, 2014.
Read more...
 

Stellar Biotechnologies and Biovest International Sign KLH Supply Agreement for BiovaxID Immunotherapy for Follicular Non-Hodgkin's Lymphoma

Print E-mail
By David Fowler   
Thursday, 23 October 2014 18:13
Below is a look at some of the headlines for companies that made news in the healthcare sector on October 23, 2014.
Read more...
 

Harvoni Approved For The Treatment Of Chronic Hepatitis C; TapImmune Provides Update on PolyStart™ Vaccine Platform

Print E-mail
By William Kent   
Wednesday, 22 October 2014 19:04
Below is a look at some of the headlines for companies that made news in the healthcare sector on October 22, 2014.
Read more...
 

Agios Pharma Reports Initiation of Phase 1/2 Clinical Trial of AG-221; Pluristem Advances its Second Major Cell Therapy Product Line

Print E-mail
By Mary Davila   
Tuesday, 21 October 2014 18:35

Below is a look at some of the headlines for companies that made news in the healthcare sector on October 21, 2014.

Read more...
 

CytRx Announces Publication of Phase 1b/2 Aldoxorubicin; NewLink Genetics Announces Licensing Agreement For Development Of NLG919

Print E-mail
By Marilyn Mullen   
Monday, 20 October 2014 19:35
Below is a look at some of the headlines for companies that made news in the healthcare sector on October 20, 2014.
Read more...
 

Pharmacyclics Enters Into Agreement with Roche to Evaluate IMBRUVICA® and GAZYVA®; Infinity Reports Data From Duvelisib Phase 2a Study

Print E-mail
By Josh Gee   
Thursday, 16 October 2014 18:39

Below is a look at some of the headlines for companies that made news in the healthcare sector on October 16, 2014.

Read more...
 
<< Start < Prev 1 3 4 5 6 7 8 9 10 > End >>

Page 1 of 349

Newsletter

BioMedReports Immunomedics Provides Update On Phase 2 Study Of Isactuzumab Govitecan; Hemispherx Reports New Evidence of Amp... http://t.co/z7wEE2pkui
21hreplyretweetfavorite
BioMedReports Movers: Johnson & Johnson, Perrigo Company, AstraZeneca, Acadia Healthcare Company, Charles River Laboratories... http://t.co/sF6jvpM24E
BioMedReports Cara Therapeutics Announces Positive Results Of Peripheral Opioid; POZEN Appoints Senior VP and Chief Business... http://t.co/yoqxKE9IsH
Benzinga.com supporter Seeking Alpha Certified